By Jul 27, 2009, 4:34 PM 

Amgen (AMGN) reported a better-than-expected second-quarter profit Monday, helped by a strong rebound in sales of its rheumatoid arthritis drug and a tax benefit, and the company raised its full-year earnings forecast. The world’s largest biotechnology company posted a net profit of $1.27 billion, or $1.25 per share, compared with a profit of $906 million, or 84 cents per share, a year ago.

Leave a Comment

Our Partners: